Information mining in patent filings on injectable antineoplastics as a contribution to Health Policy

Authors

DOI:

https://doi.org/10.33448/rsd-v11i12.33848

Keywords:

Antineoplastics; Health Information ; Cancer; Health policy.

Abstract

Introduction: According to data from the United Nations, cancer is the second leading cause of death in the world. Currently, information management has been increasingly difficult due to the large amount of data to be managed. In general, the databases that store patent documents make it possible to read them in full, but do not allow the extraction and treatment of large amounts of data. In this sense, it is necessary to use management software. Objective: To identify, extract, process the data, organize, and make available, in the form of graphical interfaces, the technological information on injectable oncology described in the current patents. Methodology: Patents deposited between January 2002 and July 2022 were analyzed using the ORBIT Intelligence® platform. In the “Advanced Search” field, the “Title, Abstract” filters were applied and the search terms: “injectable AND cancer” were used. Results and Discussion: 115 patent families were identified. The USA stands out in the number of patent documents filed, presenting a total of 56 documents. Inventors Ivan Edward Hofman, Farber Michael, Franco Rodriguez Guillermo and Gutierro Aduriz Ibon were the most productive, each with 3 documents deposited. The institutions Bespoke Bioscience (USA), Immunocore Holdings (United Kingdom) and Mountain Valley MD Holding (Canada) stood out, each holding 3 documents. In the documents analyzed, the most recurrent technological domain went beyond the "pharmaceutical" technological domain, which obtained 109 documents and others such as chemical, biological, electrical, micro and nanotechnology. Final Considerations: The results obtained by mining the data extracted from patent documents proved to be efficient and, can be useful as an effective tool to analyze, compare and monitor research and innovation activities in injectable oncology.

Author Biographies

Henrique Koch Chaves, Fundação Oswaldo Cruz; Instituto de Tecnologia em Fármacos/Farmanguinhos

I am currently a postdoctoral fellow at Fiocruz, working with Big Data in Public Health (2021). The investigations are carried out through the elaboration of prospective and technological scenarios with information science, Competitive Intelligence and Knowledge Management tools. Included in this context is the analysis of BIG DATA, Web 2.0, Health 2.0, Technological Trends, Marketing, Patents and Knowledge Translation. I have a master's degree and a PhD in Analytical and Inorganic Chemistry from the University of São Paulo (USP), having experience in the following subjects: 1) organometallic compounds, ruthenium complexes for homogeneous catalysis, polymers, olefin metathesis; 2) rhenium and technetium complex for pharmacological and medicinal applications, including applications as antitumor agents. Graduated in Chemistry from the State University of Santa Cruz (UESC).

Carla Cristina de Freitas da Silveira, Fundação Oswaldo Cruz; Instituto de Tecnologia em Fármacos/Farmanguinhos

PhD in Collective Health - Institute of Social Medicine (IMS) of the State University of Rio de Janeiro - UERJ (2016). Postgraduate in Management of Health Science and Technology Organizations - Fiocruz National School of Public Health (ENSP) (2014). Postgraduate in Civil Law and Civil Procedure - Universidade Gama Filho (2010). Bachelor of Laws - Estácio de Sá University (2008). Master in Science - Organic Chemistry - Federal University of Rio de Janeiro - UFRJ (1998). Bachelor in Chemistry with Technological Attributions (1992) and Degree in Chemistry (1991) - Faculty of Humanities Pedro II. She is currently a Health Management Analyst in Farmanguinhos, where she works as Coordinator of the Technological Innovation Center (NIT-FAR) of the Institute of Technology in Pharmaceuticals - FARMANGUINHOS/FIOCRUZ, Head Professor of the Lato Sensu Postgraduate Program in Pharmaceutical Industrial Technologies - TIF of Farmanguinhos/FIOCRUZ and Professor at the State Department of Education of Rio de Janeiro (SEEDUC), where he teaches Chemistry. She acted as: Intellectual Property Consultant at CENPES / PETROBRAS (2005-2009); Technical Consultant in the area of ​​Industrial Property of Pharmaceutical Products and Processes in the Coordination of Intellectual Property (COOPI) of the National Health Surveillance Agency - ANVISA (2001-2005); Patent Analyst at the National Institute of Industrial Property - INPI (1998-2000); Member of the team responsible for structuring a Patent Database in the field of Fine Chemicals (Project: ALERT PATENTES) at the Brazilian Association of Fine Chemical Industries - ABIFINA (1993-1994). She has experience in the field of Chemistry and Medicines with an emphasis on Industrial Property. Judicial expert at the 9th and 17th VFRJ.

Adelaide Maria de Souza Antunes , Universidade Federal do Rio de Janeiro, Instituto de Química; Instituto Nacional da Propriedade Industrial

Senior Specialist at INPI - National Institute of Industrial Property, permanent professor of the Professional Master's and Professional Doctorate in IP and Innovation at the INPI, is Professor Emerita at UFRJ and permanent professor of the academic master's and doctorate of Chemical and Biochemical Process Engineering at the School of Chemistry at the Federal University of Rio de Janeiro. She holds the titles of Chemical Engineer (EQ/UFRJ, 1976), Master in Chemical Engineering (PEQ-COPPE, 1979), Doctor in Chemical Engineering (PEQ-COPPE/UFRJ, 1987) and Post-Doctorate from the French Petroleum Institute - IFP , France (1988); Executive MBA COPPEAD - 1991Member of the Technology Commission of the Brazilian Chemical Industry Association _ ABIQUIM, Counselor of the laboratories: LABCOM® - Laboratory of Fuels and Petroleum Derivatives, and of the - Information System on the Chemical Industry; SIQUIM ® Participant of the National Institute of Science and Technology of Drugs and Medicines - INCT - INOFAR _ Works in research on: chemical industry, fine chemicals, petroleum, fuels, petrochemicals, alternative energy sources, patents, technological prospecting and future study oriented 128 master's and doctoral students and is the author of several articles and book chapters.

Jorge Lima de Magalhães, Universidade NOVA de Lisboa; University of Aveiro; Fundação Oswaldo Cruz; Instituto de Tecnologia em Fármacos/Farmanguinhos

He holds a postdoctoral degree from Aix Marseille Université, France (Laboratoire IRSIC EA4262 - Institut de Recherche en Sciences de lInformation et de la Communication) in Competitive Intelligence for Public Health (2013). He holds a Doctor of Science degree from the Postgraduate Program in Chemical and Biochemical Process Technology at EQ / UFRJ-area of ​​Management and Technological Innovation (2010) and a Master of Science from the same program (2007). He has a specialization in Business Administration and Management from Faculdades Simonsen (1998) and is an Industrial Chemist with a Full Degree from the Faculty of Philosophy Sciences and Letters Souza Marques (1996). He has more than 20 years of experience in Strategic Management in Pharmaceutical Industrial Operations. In the last 20 years, he has dedicated himself to R,D&I in the area of ​​Public Health at FIOCRUZ, where he has published 5 books, 35 book chapters and several articles in national and international indexed journals. He works in Management and Technological Innovation at the Technological Innovation Center (NIT-Far) of the Farmanguinhos Institute of Technology in Pharmaceuticals / FIOCRUZ. In CNPq Research groups, he is the leader of the Knowledge Management and Health Prospecting group at FIOCRUZ, participates in the Chemical Industry Information System-SIQUIM at UFRJ and in the Technological Prospecting in Intellectual Property group at INPI. He is a guest researcher at the Global Health and Tropical Medicine (GHMT) of the Institute of Hygiene and Tropical Medicine (IHMT) at the NOVA University of Lisbon. Founding member of the International Platform for Science, Technology and Innovation in Health (PICTIS) and coordinator of the LabSec Pharmaceuticals, Medicines and Bioproducts of PICTIS at the University of Aveiro). The emphasis of his research permeates the identification, extraction and analysis of essential information within the "Big data" in Health regarding Management and Technological Innovation. The topics covered are inherent to Global Health, involving the pharmaceutical, pharmochemical and public health sectors. The investigations are carried out through the elaboration of prospective and technological scenarios with tools from information science, Competitive intelligence and Knowledge Management for Global Health and "One Health". This context includes the analysis of Big Data in health, business strategy in the pharmaceutical area, Digital Health, Technological Trends, Marketing, Patents and Knowledge Translation.

References

ABRALE. (2020) “Manipulação de antineoplásicos: conheça os aspectos que promovem segurança”. Abrale. (https://www.abrale.org.br/noticias/manipulacao-de-antineoplasicos-conheca-os-aspectos-que-promovem-seguranca/).

Alberts, D., Yang, C. B., obare-DePonio, D., Ken Koubek, F., Robins, S., Rodgers, M., Simmons, E., & DeMarco, D. (2011) “Introduction to Patent Searching”. P. 3–43 em Current Challenges in Patent Information Retrieval, The Information Retrieval Series, organizado por M. Lupu, K. Mayer, J. Tait, e A. J. Trippe. Berlin, Heidelberg: Springer.

Al-Lazikani, B., Banerji, U., & Workman, P. (2012) “Combinatorial Drug Therapy for Cancer in the Post-Genomic Era”. Nature Biotechnology 30(7):679–92. 10.1038/nbt.2284.

Amparo, K. K. S., Ribeiro, M. C. O., & Guarieiro, L. L. N. (2012) “Estudo de caso utilizando mapeamento de prospecção tecnológica como principal ferramenta de busca científica”. Perspectivas em Ciência da Informação 17(4):195–209. 10.1590/S1413-99362012000400012.

Anon. (2014) “ASHP Guidelines on Compounding Sterile Preparations”. American Journal of Health-System Pharmacy 71(2):145–66. 10.2146/sp140001.

Equipe Oncoguia. (2015) “[MATÉRIA] Em Busca de Novos Tratamentos para o Câncer - Instituto Oncoguia”. (http://www.oncoguia.org.br/conteudo/materia-em-busca-de-novos-tratamentos-para-o-cancer/833/8/).

Guerreiro, E. S., Daltro, L. M. O., Ribeiro, N. M., & Souza, E. R. (2018) “Análise De Documentos De Patentes Sobre Copaiba: Uma Comparação Entre Fontes De Dados”. Cadernos de Prospecção 11(1):26–26. 10.9771/cp.v11i1.22725.

Hanney, S. R., Castle-Clarke, S., Grant, J., Guthrie, S., Henshall, C., Mestre-Ferrandiz, J., Pistollato, M., Pollitt, A., Sussex, J., & Wooding, S. (2015) “How Long Does Biomedical Research Take? Studying the Time Taken between Biomedical and Health Research and Its Translation into Products, Policy, and Practice”. Health Research Policy and Systems 13:1. 10.1186/1478-4505-13-1.

Holohan, C., Schaeybroeck, S. V., Longley, D. B., & Johnston, P. G. (2013) “Cancer Drug Resistance: An Evolving Paradigm”. Nature Reviews. Cancer 13(10):714–26. 10.1038/nrc3599.

INCA. (2018) “Fases de desenvolvimento de um novo medicamento”. INCA - Instituto Nacional de Câncer. (https://www.inca.gov.br/pesquisa/ensaios-clinicos/fases-desenvolvimento-um-novo-medicamento).

Longa, L. C. D. (2007). “Dissertação apresentada com vistas à obtenção do título de Mestre Modalidade Profissional em Saúde Pública.”

Magalhães, J. L., Hartz, Z., Menezes, M. S., & Quoniam, L. 2018. “Big Data e a saúde negligenciada em dengue, zika e chicungunha: uma análise translacional da tríplice ameaça no século 21”. Pesquisa Brasileira em Ciência da Informação e Biblioteconomia 13(1). 10.22478/ufpb.1981-0695.2018v13n1.39279.

Mahnken, T. A., & Martin, G. M. 2018. “Multi-Cross-Industry Innovation Patents in the USA - A Combination of PATSTAT and Orbis Search”. World Patent Information 55:52–60. 10.1016/j.wpi.2018.10.003.

Matz, E. L., & Hsieh, M. H. 2017. “Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-Induced Hemorrhagic Cystitis”. Urology 100:16–19. 10.1016/j.urology.2016.07.030.

McGaugh, J. L. 1973. “Drug Facilitation of Learning and Memory”. Annual Review of Pharmacology 13(1):229–41. 10.1146/annurev.pa.13.040173.001305.

Mohiuddin, A. K. 2020. “Extemporaneous Compounding: Cautions, Controversies and Convenience”. IP International Journal of Comprehensive and Advanced Pharmacology 3(4):124–37. 10.18231/2456-9542.2018.0028.

Oun, R., Moussa, Y. E., & Wheate, N. J. 2018. “The Side Effects of Platinum-Based Chemotherapy Drugs: A Review for Chemists”. Dalton Transactions (Cambridge, England: 2003) 47(19):6645–53. 10.1039/c8dt00838h.

Pergolizzi Jr, J. V., Labhsetwar, S., & LeQuang, J. A. 2013. “Compounding Pharmacies: Who Is in Charge?” Pain Practice 13(3):253–57. 10.1111/papr.12033.

Ramos, M. J., Rito, P. N., & Vieira, V. V. 2021. “Monitoramento ambiental na manipulação de medicamentos oncológicos injetáveis à luz das normativas vigentes”. Vigilância Sanitária em Debate 9(2):3–13.

Rocha, E. S. B., Nagliate, P., Furlan, C. E. B., Rocha Jr, K., Trevizan, M. A., & Mendes, I. A. C. 2012. “Knowledge management in health: a systematic literature review”. Revista Latino-Americana de Enfermagem 20(2):392–400. 10.1590/S0104-11692012000200024.

Rossetti, A., & Morales, A. B. 2007. “O papel da tecnologia da informação na gestão do conhecimento”. Ciência da Informação 36(1):124–35. 10.1590/S0100-19652007000100009.

Sag, A. A., Selcukbiricik, F., & Mandel, N. M. 2016. “Evidence-Based Medical Oncology and Interventional Radiology Paradigms for Liver-Dominant Colorectal Cancer Metastases”. World Journal of Gastroenterology 22(11):3127–49. 10.3748/wjg.v22.i11.3127.

Santos, F. B., Alves, T. M., Queiroz, D. G. C., Brandão, F. G., Junior, R. F. G., & Moura, A. M. M. 2019. “Inovação tecnológica da UFRGS: uma análise da colaboração identificada nas patentes indexadas na base Orbit”. InCID: Revista de Ciência da Informação e Documentação 10(2):92–114. 10.11606/issn.2178-2075.v10i2p92-114.

Santos, G. B. 2022. “A Sociedade Digital É Terra Sem Lei? O Direito Autoral Na Era Da Internet.” Revista de Direito, Inovação, Propriedade Intelectual e Concorrência 7(2):59. 10.26668/IndexLawJournals/2526-0014/2021.v7i2.8304.

Soares, J. M., Correa, M. C. D. V., & Lage, L. E. C. 2010. “Patentes de formas polimórficas na área de fármacos no Brasil e o impacto na saúde pública”. Revista Eletrônica de Comunicação, Informação e Inovação em Saúde 4(2). 10.3395/reciis.v4i2.679.

Speziali, M. G., & Nascimento, R. S. 2020. “Patentometria: uma ferramenta indispensável no estudo de desenvolvimento de tecnologias para a indústria química”. Quimica Nova 43(10):1538–48. 10.21577/0100-4042.20170620.

Teixeira, L. P. 2013. “Prospecção tecnológica: importância, métodos e experiências da Embrapa Cerrados”. 34.

WHO. 2021. “Câncer de mama agora forma mais comum de câncer: OMS tomando medidas”. (https://www.who.int/pt/news/item/03-02-2021-breast-cancer-now-most-common-form-of-cancer-who-taking-action).

Downloads

Published

07/09/2022

How to Cite

CHAVES, H. K.; SILVEIRA, C. C. de F. da; ANTUNES , A. M. de S.; MAGALHÃES, J. L. de. Information mining in patent filings on injectable antineoplastics as a contribution to Health Policy . Research, Society and Development, [S. l.], v. 11, n. 12, p. e82111233848, 2022. DOI: 10.33448/rsd-v11i12.33848. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/33848. Acesso em: 25 apr. 2024.

Issue

Vol. 11 No. 12

Section

Health Sciences

License

Copyright (c) 2022 Henrique Koch Chaves; Carla Cristina de Freitas da Silveira; Adelaide Maria de Souza Antunes ; Jorge Lima de Magalhães

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.